Catalyst Wire Dossier Catalyst Wire Dossier

Foretinib

foretinib · GlaxoSmithKline
Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for Foretinib, covering 2014-05-19 to 2023-08-04. Get the full timeline:

Most recent: Clinical Trial Update: Study of Foretinib in Combination With Lapatinib in Patients With Metastatic Breast Cancer [Phase 1, Phase 2]

See pricing